Illumina Boosts Convertible Note Offering to $350M from $325M

Feb 13, 2007

NEW YORK (GenomeWeb News) — Illumina has increased by $25 million a convertible note offering it disclosed yesterday, making the total sale worth $350 million, the company said today.

The company said it plans to use the proceeds to pay for corporate expenses, and will use around $202 million of it to buy back its own stock or cover acquisition costs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

Main menu